肩袖钙化性肌腱炎穿刺抽吸后辅助应用富血小板血浆的疗效:双盲随机对照试验2年随访
这项双盲随机对照试验纳入80例有症状的肩袖钙化性肌腱炎成人,比较穿刺抽吸钙化灶后辅助注射富血小板血浆(NACD+PRP)与常规穿刺抽吸加皮质类固醇(NACD+皮质类固醇)对疼痛、肩功能和生存质量的影响。结果显示NACD+PRP在6周时临床评分较差,6个月时较好,1年和2年时两组相当;PRP可能减少额外治疗需求但并发症更多。结论认为NACD+皮质类固醇早期效果良好且合并症低,仍是首选治疗。
要点
- NACD+PRP在6周时临床评分劣于NACD+皮质类固醇,6个月时优于后者。
- 1年和2年随访时两组临床结果相当。
- PRP组二次NACD需求较低但并发症更多,NACD+皮质类固醇仍是首选。
核心结论
- NACD+PRP在6周随访时临床评分较差,在6个月随访时较好,1年和2年随访时两组结果相当。
- PRP似乎减少额外治疗需求但并发症更多,NACD+皮质类固醇仍是肩袖钙化性肌腱炎的首选治疗。
研究设计与样本
- 单中心、双盲、随机对照试验,证据等级1级,共纳入80例有症状的肩袖钙化性肌腱炎成人。
- 48例女性,平均年龄49±6岁,NACD+PRP组41例。
- 随机分配至NACD+皮质类固醇组或NACD+PRP组,随访至24个月。
主要发现
- 两组所有临床评分在2年随访时均改善(P < .001)。
- NRS评分平均下降值NACD+PRP组为4.34,NACD+皮质类固醇组为3.56,NACD+PRP非劣效于NACD+皮质类固醇(P = .003)。
- 混合模型分析显示NACD+PRP组在CMS(P < .001)、DASH(P = .002)、OSS(P = .010)、EQ-5D(P < .001)上更优。
- 临床相关差异仅见于6个月随访时NRS和CMS favoring NACD+PRP,6周随访时除NRS外所有临床评分临床相关差异favoring NACD+皮质类固醇。
- 钙化灶完全吸收率NACD+PRP组84% vs NACD+皮质类固醇组66%(P = .081);二次NACD需求NACD+PRP组10例(24%)vs NACD+皮质类固醇组19例(49%)(P = .036);并发症NACD+PRP组6例(其中5例冻结肩)vs NACD+皮质类固醇组1例(P = .11)。
关键数值与推荐
- NRS评分平均下降值:NACD+PRP组4.34,NACD+皮质类固醇组3.56,非劣效分析P = .003。
- 完全吸收率:NACD+PRP组84%,NACD+皮质类固醇组66%(P = .081)。
- 二次NACD比例:NACD+PRP组24%(10例),NACD+皮质类固醇组49%(19例)(P = .036)。
- 并发症:NACD+PRP组6例(5例冻结肩),NACD+皮质类固醇组1例(P = .11)。
临床怎么用
- 对于肩袖钙化性肌腱炎患者,NACD+皮质类固醇可作为首选,因其早期疼痛和功能改善良好且合并症低。
- 若考虑辅助应用PRP,需权衡6个月时可能的临床获益与更高的并发症风险及二次治疗需求降低。
局限性
- 单中心研究,样本量80例,可能影响结果外推性。
- 并发症发生率组间比较P = .11,未达统计学显著。
- 临床相关差异仅见于特定时间点,长期优势不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Needle aspiration of calcific deposits (NACD) is a frequently used treatment for rotator cuff calcific tendinitis (RCCT). However, a substantial number of patients experience recurrent or persisting shoulder symptoms after NACD. PURPOSE: To compare the effects of adjuvant application of platelet-rich plasma (PRP) after NACD (NACP+PRP) with those of conventional NACD with corticosteroids (NACD+corticosteroids) on pain, shoulder function, and quality of life (QoL). STUDY DESIGN: Randomized controlled trial; Level of evidence, 1. METHODS: In a single-center, double-blinded, randomized controlled trial, 80 adults with symptomatic RCCT were randomly allocated to receive NACD+corticosteroids or NACD+PRP. Pain, shoulder function, and QoL were assessed at baseline; 6 weeks; and 3, 6, 12, and 24 months after treatment using a numeric rating scale for pain (NRS); the Constant-Murley score (CMS); the Disabilities of the Arm, Shoulder and Hand questionnaire (DASH); the Oxford Shoulder Score (OSS); and the EuroQol 5-dimension scale (EQ-5D). Additionally, resorption of calcific deposits and the integrity of rotator cuff tendons were assessed by using standard radiographs and ultrasound examination, respectively. The results were analyzed using noninferiority analysis for NRS scores and a mixed model for repeated measures. RESULTS: Eighty patients were included (48 female; mean age, 49 ± 6 years; 41 patients in the NACD+PRP group). Both groups showed improvement of clinical scores at the 2-year follow-up (P < .001 for all clinical scores). NACD+PRP was found to be noninferior to NACD+corticosteroids with regard to the mean decrease of NRS scores (4.34 vs 3.56; P = .003). Mixed-model analysis showed a significant difference in favor of NACD+PRP (CMS, P < .001; DASH, P = .002; OSS, P = .010; EQ-5D, P < .001). However, clinically relevant differences in favor of NACD+PRP were only seen at the 6-month follow-up for NRS and CMS scores, whereas at the 6-week follow-up a clinically relevant difference in favor of NACD+corticosteroids was found for all clinical scores except for the NRS. Full resorption of calcific deposits was present in 84% of the NACD+PRP group compared with 66% in the NACD+corticosteroids group (P = .081). In the NACD+PRP group, 10 (24%) patients required a second NACD procedure compared with 19 (49%) patients in the NACD+corticosteroids group (P = .036). Six complications, of which 5 were frozen shoulders, occurred in the NACD+PRP group compared with 1 complication in the NACD+corticosteroids group (P = .11). CONCLUSION: NACD+PRP resulted in worse clinical scores at the 6-week follow-up but better clinical scores at the 6-month follow-up compared with NACD+corticosteroids. At the 1- and 2-year follow-ups, the results were comparable between groups. Furthermore, PRP seemed to reduce the need for additional treatments but was associated with more complications. In conclusion, NACD+corticosteroids had a favorable early effect on pain and function combined with low comorbidity. Thus, it remains the treatment of choice for patients with RCCT. REGISTRATION: NCT02173743 (ClinicalTrials.gov identifier).
引用
- Oudelaar BW, Huis In 't Veld R, Ooms EM, et al. Efficacy of Adjuvant Application of Platelet-Rich Plasma After Needle Aspiration of Calcific Deposits for the Treatment of Rotator Cuff Calcific Tendinitis: A Double-Blinded, Randomized Controlled Trial With 2-Year Follow-up. Am J Sports Med. 2021. PMID: 33566629. doi:10.1177/0363546520987579
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。